BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19434748)

  • 1. Critical review of indications for renal artery stenting: do randomized trials give the answer?
    Schwarzwälder U; Zeller T
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):251-6. PubMed ID: 19434748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal artery stenosis: epidemiology, clinical manifestation, and percutaneous endovascular therapy.
    Zeller T
    J Interv Cardiol; 2005 Dec; 18(6):497-506. PubMed ID: 16336432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications, technique and outcome of endovascular treatment of renal artery stenosis.
    Zeller T
    Minerva Cardioangiol; 2007 Feb; 55(1):115-23. PubMed ID: 17287686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of diagnosis and endovascular treatment of renal artery stenosis.
    Zeller T
    Vasa; 2006 Aug; 35(3):147-55. PubMed ID: 16941403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal artery stenosis: Up-date on diagnosis and treatment.
    Zeller T; Macharzina R; Rastan A; Beschorner U; Noory E
    Vasa; 2014 Jan; 43(1):27-38. PubMed ID: 24429328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trials in angioplasty and stenting of the renal artery: tabular review of the literature and critical analysis of their results.
    Escobar GA; Campbell DN
    Ann Vasc Surg; 2012 Apr; 26(3):434-42. PubMed ID: 22305685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous endovascular therapy of renal artery stenosis: technical and clinical developments in the past decade.
    Zeller T
    J Endovasc Ther; 2004 Dec; 11 Suppl 2():II96-106. PubMed ID: 15760249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the management of atherosclerotic renal artery disease.
    Fenstad ER; Kane GC
    Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal angioplasty and stenting: is it still indicated after ASTRAL and STAR studies?
    Henry M; Benjelloun A; Henry I; Polydorou A; Hugel M
    J Cardiovasc Surg (Torino); 2010 Oct; 51(5):701-20. PubMed ID: 20924331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of percutaneous revascularization for renal artery stenosis.
    Dubel GJ; Murphy TP
    Vasc Med; 2008; 13(2):141-56. PubMed ID: 18593803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence and critique of the ASTRAL and CORAL Trials.
    Sarac TP
    Semin Vasc Surg; 2011 Sep; 24(3):162-6. PubMed ID: 22153027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based medicine in renal artery stenting.
    Rabbia C; Pini R
    J Cardiovasc Surg (Torino); 2010 Oct; 51(5):755-63. PubMed ID: 20924335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice.
    Cianci R; Gigante A; Polidori L; Di Donato D; Martina P; Barbano B; Renzulli R; Zaccaria A; Fuiano G
    Angiology; 2009; 60(4):496-503. PubMed ID: 18796449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous vascular interventions in renal artery diseases.
    Kolluri R; Goldstein JA; Rocha-Singh K
    Minerva Cardioangiol; 2006 Feb; 54(1):95-107. PubMed ID: 16467745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.
    Kumbhani DJ; Bavry AA; Harvey JE; de Souza R; Scarpioni R; Bhatt DL; Kapadia SR
    Am Heart J; 2011 Mar; 161(3):622-630.e1. PubMed ID: 21392620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary stenting for atherosclerotic renal artery stenosis.
    Steichen O; Amar L; Plouin PF
    J Vasc Surg; 2010 Jun; 51(6):1574-1580.e1. PubMed ID: 20488331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
    Cooper CJ; Murphy TP; Matsumoto A; Steffes M; Cohen DJ; Jaff M; Kuntz R; Jamerson K; Reid D; Rosenfield K; Rundback J; D'Agostino R; Henrich W; Dworkin L
    Am Heart J; 2006 Jul; 152(1):59-66. PubMed ID: 16824832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study.
    Zeller T; Krankenberg H; Erglis A; Blessing E; Fuss T; Scheinert D; Weser R; Doerr BB; Yollo WD; Radermacher J;
    Trials; 2017 Aug; 18(1):380. PubMed ID: 28807045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenting for atherosclerotic renal artery stenosis: one poorly designed trial after another.
    Weinberg MD; Olin JW
    Cleve Clin J Med; 2010 Mar; 77(3):164-71. PubMed ID: 20200167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.